Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation

Liver Transplantation

Volumn 20, Issue 12, 2014, Pages 1508-1519

  Prakoso, Emilia ^a,b,c   Tirnitz Parker, Janina E E ^d,e   Clouston, Andrew D ^f   Kayali, Zeid ^g   Lee, Aimei ^a,c   Gan, Eng K ^e,h   Ramm, Grant A ⁱ   Kench, James G ^b,c   Bowen, David G ^a,b,c   Olynyk, John K ^d,h,j   McCaughan, Geoffrey W ^a,b,c   Shackel, Nicholas A ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^h FREMANTLE HOSPITAL   (Australia)

ⁱ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^j MURDOCH UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD45 ANTIGEN;

ADULT; AGED; ARTICLE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CHOLESTASIS; CONFOCAL MICROSCOPY; FATTY LIVER; FEMALE; HEPATIC PROGENITOR CELL; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRAHEPATIC DUCTULAR REACTION; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PORTAL VEIN; PROTHROMBIN TIME; RECURRENT DISEASE; RETROSPECTIVE STUDY; STELLATE CELL; THROMBOCYTE COUNT; VIRUS LOAD; ADVERSE EFFECTS; CLINICAL TRIAL; COMPLICATION; CYTOLOGY; DISEASE COURSE; FIBROSIS; FLUORESCENCE MICROSCOPY; HEPACIVIRUS; HEPATIC DUCT; INFLAMMATION; LIVER FAILURE; MULTICENTER STUDY; PATHOLOGY; STEM CELL; TREATMENT OUTCOME; VIROLOGY;

AGED; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FIBROSIS; HEPACIVIRUS; HEPATIC DUCT, COMMON; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STEM CELLS; TREATMENT OUTCOME;

EID: 84912130508     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.24007     Document Type: Article

References (55)

1. Prakoso E, Verran D, Dilworth P, Kyd G, Tang P, Tse C, et al. Increasing liver transplantation waiting list mortality: a report from the Australian National Liver Transplantation Unit, Sydney. Intern Med J 2010; 40: 619-625.
2. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2010 Annual Data Report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011:chap 3.
3. Lynch SV, Balderson GA, eds. Australia and New Zealand Liver Transplant Registry Report 2010. http://www.anzltr.org/statistics.html. Accessed September 2014.
4. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR,. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
5. Féray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994; 20: 1137-1143.
6. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996; 334: 815-820.
7. Féray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619-625.
8. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J,. Hepatitis C viral infection in liver transplant recipients. Hepatology 1992; 16: 865-876.
9. Martin P, Muñoz SJ, Di Bisceglie AM, Rubin R, Waggoner JG, Armenti VT, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 1991; 13: 719-721.
10. Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256.
11. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayón M, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673-684.
12. Gane E,. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl 2003; 9: S28-S34.
13. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR,. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 2005; 41: 809-818.
14. Lowes KN, Croager EJ, Abraham LJ, Olynyk JK, Yeoh GC,. Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut 2003; 52: 1327-1332.
15. Lowes KN, Brennan BA, Yeoh GC, Olynyk JK,. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am J Pathol 1999; 154: 537-541.
16. Jakubowski A, Ambrose C, Parr M, Lincecum JM, Wang MZ, Zheng TS, et al. TWEAK induces liver progenitor cell proliferation. J Clin Invest 2005; 115: 2330-2340.
17. Tirnitz-Parker JE, Viebahn CS, Jakubowski A, Klopcic BR, Olynyk JK, Yeoh GCT, Knight B,. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Hepatology 2010; 52: 291-302.
18. Tirnitz-Parker JE, Tonkin JN, Knight B, Olynyk JK, Yeoh GC,. Isolation, culture and immortalisation of hepatic oval cells from adult mice fed a choline-deficient, ethionine-supplemented diet. Int J Biochem Cell Biol 2007; 39: 2226-2239.
19. Tsuchiya A, Lu WY, Weinhold B, Boulter L, Stutchfield BM, Williams MJ, et al. Polysialic acid/neural cell adhesion molecule modulates the formation of ductular reactions in liver injury. Hepatology 2014; 60: 1727-1740.
20. Roskams T, Desmet V,. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998; 15: 259-269.
21. Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163: 1301-1311.
22. Roskams T,. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin Liver Dis 2008; 12: 853-860.
23. Ruddell RG, Knight B, Tirnitz-Parker JE, Akhurst B, Summerville L, Subramaniam VN, et al. Lymphotoxin-beta receptor signaling regulates hepatic stellate cell function and wound healing in a murine model of chronic liver injury. Hepatology 2009; 49: 227-239.
24. Ruddell RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA,. A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am J Pathol 2006; 169: 861-876.
25. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, et al. Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 1999; 29: 140-148.
26. Friedman SL,. Cellular and molecular pathobiology of liver fibrosis and its pharmacological intervention. In:, Rodes J, Benhamou JP, Blei A, Reichen J, Rizzetto M, eds. The Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. New York, NY: Blackwell Publishing; 2007.
27. Alvaro D, Mancino MG, Glaser S, Gaudio E, Marzioni M, Francis H, Alpini G,. Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. Gastroenterology 2007; 132: 415-431.
28. Svegliati-Baroni G, De Minicis S, Marzioni M,. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Liver Int 2008; 28: 1052-1064.
29. Williams MJ, Clouston AD, Forbes SJ,. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology 2014; 146: 349-356.
30. Meriden Z, Forde KA, Pasha TL, Hui JJ, Reddy KR, Furth EE, Wells RG,. Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection. Clin Gastroenterol Hepatol 2010; 8: 289-296.
31. Roskams T, Desmet V,. Ductular reaction and its diagnostic significance. Semin Diagn Pathol 1998; 15: 259-269.
32. Liew PL, Wang W, Lee YC, Huang MT, Lee WJ,. Roles of hepatic progenitor cells activation, ductular reaction proliferation and Notch signaling in morbid obesity. Hepatogastroenterology 2012; 59: 1921-1927.
33. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 2007; 133: 80-90.
34. Scheuer PJ,. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-374.
35. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, Powell EE,. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 2001; 34: 314-320.
36. Clouston AD, Powell EE,. Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002; 16: 767-781.
37. Gochee PA, Jonsson JR, Clouston AD, Pandeya N, Purdie DM, Powell EE,. Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1. J Gastroenterol Hepatol 2003; 18: 386-392.
38. Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002; 51: 89-94.
39. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, Powell EE,. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999; 29: 1215-1219.
40. Powell EE, Jonsson JR, Clouston AD,. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42: 5-13.
41. Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE,. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230-1238.
42. Gouw AS, Clouston AD, Theise ND,. Ductular reactions in human liver: diversity at the interface. Hepatology 2011; 54: 1853-1863.
43. Michalopoulos GK,. Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 2011; 43: 173-179.
44. Falkowski O, An HJ, Ianus IA, Chiriboga L, Yee H, West AB, Theise ND,. Regeneration of hepatocyte "buds" in cirrhosis from intrabiliary stem cells. J Hepatol 2003; 39: 357-364.
45. Marshall A, Rushbrook S, Davies SE, Morris LS, Scott IS, Vowler SL, et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology 2005; 128: 33-42.
46. Tillmann HL, Manns MP, Rudolph KL,. Merging models of hepatitis C virus pathogenesis. Semin Liver Dis 2005; 25: 84-92.
47. Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW,. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transpl 2005; 11: 1235-1241.
48. Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ,. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl 2005; 11: 1207-1213.
49. Irie T, Asahina K, Shimizu-Saito K, Teramoto K, Arii S, Teraoka H,. Hepatic progenitor cells in the mouse extrahepatic bile duct after a bile duct ligation. Stem Cells Dev 2007; 16: 979-987.
50. Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, Booth TA, et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 2007; 88: 112-123.
51. Knight B, Lim R, Yeoh GC, Olynyk JK,. Interferon-gamma exacerbates liver damage, the hepatic progenitor cell response and fibrosis in a mouse model of chronic liver injury. J Hepatol 2007; 47: 826-833.
52. Knight B, Akhurst B, Matthews VB, Ruddell RG, Ramm GA, Abraham LJ, et al. Attenuated liver progenitor (oval) cell and fibrogenic responses to the choline deficient, ethionine supplemented diet in the BALB/c inbred strain of mice. J Hepatol 2007; 46: 134-141.
53. Tirnitz-Parker JEE, Olynyk JK, Ramm GA,. Role of TWEAK in co-regulating liver progenitor cell and fibrogenic responses. Hepatology 2014; 59: 1198-1201.
54. Dwyer B, Olynyk J, Ramm G, Tirnitz-Parker JEE,. TWEAK and LT beta signaling during chronic liver disease. Front Immunol 2014; doi: 10.3389/fimmu.2014.00039.
55. Knight B, Tirnitz-Parker JE, Olynyk JK,. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice. Gastroenterology 2008; 135: 969-979.